Therapy to prevent blindness

To better Verte. The drug therapy for glaucoma can prevent blindness, but until today, this meant multiple daily doses of beta blockers and potential side effects as impotence.

The Food and Drug Administration (FDA) of the United States has approved a new drug: the latanoprost (Xalatan), which is effective in a single daily dose and has much fewer side effects. "Patients are more convinced taking latanoprost regularly," says Dr. Ronald Gross, an associate professor of ophthalmology at Baylor College of Medicine. Unfortunately, drugs obscures the iris of the eye clear of people.

The FDA recommends that doctors use medicine as a last resort, to realize what is causing the discoloration.